AstraZeneca strikes $40 million AI drug discovery deal with insitro
HealthcareLdr · x · 2026-10-17
AstraZeneca has signed a $40 million AI drug discovery deal with insitro, partnering to apply machine learning to accelerate drug development.
More from Venture
- India has only ~30,000 GPUs nationwide, 10-20x short of frontier model needs — CatAstro_Piyush · 2026-10-17
- Origin Autonomy emerges with $20M to automate interior construction, robots running 3x human speed — lukas_m_ziegler · 2026-10-17
- China doesn't need better AI—it needs to make American AI unprofitable, argues founder — r0ck3t23 · 2026-10-17
- Reddit users weigh canceling OpenAI Pro 200 subs over Nov 1 rate hike — cybrstg · 2026-10-17
- Nebius is building the next AWS; CoreWeave is a GPU datacenter OEM — kevinsxu · 2026-10-17
- Mercor's CEO: the whole company pulled an all-nighter to win a DeepMind pilot — himanshustwts · 2026-10-17